Living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003 Nov;9(11):S52-7
Date
10/31/2003Pubmed ID
14586896DOI
10.1053/jlts.2003.50256Scopus ID
2-s2.0-0242539726 (requires institutional sign-in at Scopus site) 32 CitationsAbstract
1. Hepatitis C virus (HCV) is the most common indication for living donor liver transplantation (LDLT). 2. Preliminary evidence suggests that HCV may occur earlier and may be more severe in LDLT recipients. However, current data is inconclusive relative to the impact of recurrent HCV on patient and graft survival in LDLT recipients. 3. Potential mechanisms for differences in severity of HCV in LDLT recipients are discussed. 4. LDLT remains a viable treatment option for selected patients with HCV.
Author List
Zimmerman MA, Trotter JFMESH terms used to index this publication - Major topics in bold
Antiviral AgentsGraft Survival
Hepatitis C
Humans
Liver
Liver Cirrhosis
Liver Transplantation
Living Donors
Postoperative Period
Recurrence